Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers 5-hmC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback